P Valensi, M Benroubi, V Borzi, J Gumprecht … - Int J Clin Pract, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 7 - Related articles - All 3 versions
Y Wen-ying, JI Qiu-he, ZHU Da-long, Y Jin-kui … - Chinese Medical Journal, 2009 - cmj.org In subjects with type 2 diabetes inadequately controlled with oral antidiabetic
agents (OADs), insulin therapy is usually started to improve glycaemic control
after failure of diet, exercise and OADs. 1 Although there is no standard ... Related articles - Cached - All 6 versions
Y Wen-ying, JI Qiu-he, ZHU Da-long, Y Jin-kui … - Chinese Medical Journal, 2009 - cmj.org The aim of this study was a head-to-head comparison of BID versus TID BIAsp 30
dosing in Chinese insulin-naïve subjects with type 2 diabetes after at least
six-month inadequately controlled by OAD treatment. The published data from ... Related articles - View as HTML - All 3 versions
S Shah, AK Das, A Kumar, AG Unnikrishnan, … - Advances in Therapy, 2009 - Springer Page 1. Adv Ther (2009) 26(3):325-335. DOI 10.1007/s12325-009-0006-9 ORIGINAL
RESEARCH Baseline Characteristics of the Indian Cohort from the ... Related articles - All 2 versions
A Ther - Adv Ther, 2009 - advancesintherapy.org Page 1. Adv Ther (2009) 26(3):. DOI 10.1007/s12325-009-0006-9 ORIGINAL RESEARCH
Baseline Characteristics of the Indian Cohort from the ... Related articles
J Gumprecht, G Żurawska, B Wolnik, G Dzida - Endokrynologia Polska, 2008 - viamedica.pl Janusz Gumprecht MD, Ph.D. Department of Internal Diseases, Diabetology and
Nephrology, Medical University of Silesia, ul. 3-go Maja 13–15, 41–800
Zabrze, tel.: +48 32 271 25 11, fax: +48 32 271 46 17, e-mail: ... Related articles - View as HTML - All 3 versions
陈攀， 黄涛 - 西南军医, 2009 - journal.shouxi.net Abstract Objective To compare the curative effect and safety between NovoRapid
30 and Novolin 30R in treating patients with type 2 diabetes mellitus (T2DM) who
had just started the treatment with the injection of insulin.Methods 60 ... Related articles - Cached - All 3 versions